Rome, Nov 14. (Adnkronos Health) – “A woman who receives a cancer diagnosis may experience menstrual cycle disorders, up to menopause, for two reasons. The first is related to oncological therapies, which can interfere with normal hormone production and cause the interruption of the cycle. The second concerns cases where it is necessary to induce menopause to counteract hormone-sensitive tumors, such as those of the breast, uterus, and ovary. Talking about menopause today therefore also means addressing the disorders and consequences related to the loss of the menstrual cycle. The reduction of hormones that regulate reproductive function and sexuality indeed has an impact on women’s health, regardless of whether menopause is natural or induced by oncological therapies. In both cases, hormonal changes can have clinical consequences and affect the quality of life of patients.” This was stated by Annamaria Colao, Professor of Endocrinology at the Federico II University of Naples, at the presentation of the book ‘M like Menopause’ during the XXVIII national congress of the Italian Association of Medical Oncology currently underway in Rome. The volume is co-authored by Annamaria Colao and Raffaella Cesaroni, a Sky Tg24 journalist.
The aim of the volume is to make understandable a topic that concerns all women, but which too often is addressed with excessively technical language or through stereotypes and prejudices. “Women today spend over a third of their lives in peri and post-menopause – explains Cesaroni – Life expectancy has increased, and 50 years increasingly represent a phase of new opportunities, projects, relationships, and professional paths. Yet, menopause continues to be a little-known topic and, sometimes, still difficult to address openly.” The topic also takes on particular significance in oncology. Some cancer treatments, such as chemotherapy, pelvic radiotherapy, and certain hormonal therapies, can indeed anticipate or cause menopause. In these cases, it is referred to as induced or iatrogenic menopause. This condition can also affect young women and brings with it physical, hormonal, and emotional changes, with possible repercussions on quality of life, sexuality, sleep, and psychological well-being. For these women, facing menopause often means simultaneously managing the consequences of the disease and those of the treatments.
“This is why it is important to talk about it, inform patients, and support them with multidisciplinary care, involving oncologists, endocrinologists, and gynecologists,” adds Cesaroni. “This is a further piece of the puzzle to clarify women’s health during a particular phase of their lives. For a long time, menopause, as well as women’s health in general, has been little studied. Today – emphasizes Rossana Berardi, Aiom president-elect – attention to gender oncology is growing, an area in which Aiom is strongly committed: three years ago we published the first recommendations, and now we will work on defining specific guidelines. In the past, clinical research focused predominantly on men. Women participated less also due to difficulties related to travel, required check-ups, and their role as caregivers within the family. Today the situation is changing: female participation in clinical studies has exceeded 40%, compared to 10-15% a few decades ago.”